- Karlsson, Richard;
- Chopra, Pradeep;
- Joshi, Apoorva;
- Yang, Zhang;
- Vakhrushev, Sergey Y;
- Clausen, Thomas Mandel;
- Painter, Chelsea D;
- Szekeres, Gergo P;
- Chen, Yen-Hsi;
- Sandoval, Daniel R;
- Hansen, Lars;
- Esko, Jeffrey D;
- Pagel, Kevin;
- Dyer, Douglas P;
- Turnbull, Jeremy E;
- Clausen, Henrik;
- Boons, Geert-Jan;
- Miller, Rebecca L
Heparan sulfate (HS) polysaccharides are master regulators of diverse biological processes via sulfated motifs that can recruit specific proteins. 3-O-sulfation of HS/heparin is crucial for anticoagulant activity, but despite emerging evidence for roles in many other functions, a lack of tools for deciphering structure-function relationships has hampered advances. Here, we describe an approach integrating synthesis of 3-O-sulfated standards, comprehensive HS disaccharide profiling, and cell engineering to address this deficiency. Its application revealed previously unseen differences in 3-O-sulfated profiles of clinical heparins and 3-O-sulfotransferase (HS3ST)–specific variations in cell surface HS profiles. The latter correlated with functional differences in anticoagulant activity and binding to platelet factor 4 (PF4), which underlies heparin-induced thrombocytopenia, a known side effect of heparin. Unexpectedly, cells expressing the HS3ST4 isoenzyme generated HS with potent anticoagulant activity but weak PF4 binding. The data provide new insights into 3-O-sulfate structure-function and demonstrate proof of concept for tailored cell-based synthesis of next-generation heparins.